SH3YL1
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
153896copy number gainGRCh38/hg38 2p25.3(chr2:153031-252990)x3-1-2153031252990nana
153896copy number gainGRCh38/hg38 2p25.3(chr2:153031-252990)x3-1-2153031252990nana
153896copy number gainGRCh38/hg38 2p25.3(chr2:153031-252990)x3-1-2143031242990nana
161145copy number lossGRCh38/hg38 2p25.3(chr2:186745-255735)x1-1-2186745255735nana
161145copy number lossGRCh38/hg38 2p25.3(chr2:186745-255735)x1-1-2186745255735nana
161145copy number lossGRCh38/hg38 2p25.3(chr2:186745-255735)x1-1-2176745245735nana
162272copy number lossGRCh38/hg38 2p25.3(chr2:84669-229081)x1-1-284669229081nana
162272copy number lossGRCh38/hg38 2p25.3(chr2:84669-229081)x1-1-284669229081nana
162272copy number lossGRCh38/hg38 2p25.3(chr2:84669-229081)x1-1-274669219081nana
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
2239416rs300703CTrs3007032.70E-05Type 2 diabetesHPOID:0005978DOID:9352C,TintronGWASdb_trait
2242800rs10181051TCrs101810515.38E-05NeuroblastomaHPOID:0003006DOID:769TintronGWASdb_trait
2263270rs10167992TCrs101679926.90E-04Response to TNF antagonist treatmentHPOID:0001370DOID:7148CintronGWASdb_trait
Disease associated variation - GWAS Central
Study NameSource Marker AccessionChromosomeMarker StartMarker StopAllelesGene SectionP-value-log(p-value)
GWAS of prostate cancerrs75966782262553262553intronic0.7749830.110707824057778
GWAS of prostate cancerrs14610282238975238975intronic0.7522030.123664938819964
GWAS of prostate cancerrs44551912256278256278intronic0.7347580.133855676657948
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000035115.21 SH3YL1 617314